Long-term outcomes in acute coronary syndrome patients without standard modifiable risk factors: a multi-ethnic retrospective cohort study Of 5400 asian patients Gwyneth KongNicholas W. S. ChewPoay-Huan Loh OriginalPaper 12 September 2022 Pages: 569 - 578
Utilization of D-dimer assay, CT angiography, and the incidence of pulmonary embolism in the hospital district of Helsinki and Uusimaa (2011–2017) Markus Sane BriefCommunication Open access 18 September 2022 Pages: 579 - 582
Management of potential drug-drug interactions with nirmatrelvir-ritonavir and oral anticoagulants: a case series Sara R. VazquezAaron S. WilsonDaniel M. Witt Letter to the Editor 18 October 2022 Pages: 583 - 586
SARS-CoV-2 antibody research in patients with unprovoked pulmonary embolism in COVID-19 pandemic period Ersan AtahanEmine KarabulBekir Kocazeybek OriginalPaper 19 September 2022 Pages: 587 - 592
The pharmacokinetics of recombinant FXIII (catridecacog) from the MENTORTM2 trial to a real-world study: a head-to-head comparison Samantha PascaCojutti PierGiorgioEzio Zanon; the Italian rFXIII Study Group BriefCommunication 12 September 2022 Pages: 593 - 596
Evaluation of the use of direct oral anticoagulants for the management of heparin-induced thrombocytopenia Asmaa AlbuloushiMegan RhotenJean M. Connors OriginalPaper 21 September 2022 Pages: 597 - 604
Post-thrombolytic coagulopathy and complications in patients with pulmonary embolism treated with fixed-dose systemic alteplase Matthew P. LillybladGhaziuddin A. QadriRoman R. Melamed OriginalPaper 23 March 2022 Pages: 605 - 615
Prescribing of anticoagulation for atrial fibrillation in primary care Kathryn A. MartinezMark H. EckmanMichael B. Rothberg OriginalPaper 21 April 2022 Pages: 616 - 624
Direct oral anticoagulants for the treatment of atrial fibrillation in patients with hematologic malignancies Alessandra SerraoFrancesco MalfonaAntonio Chistolini BriefCommunication 20 September 2022 Pages: 625 - 629
In-hospital prognosis of malignancy-related pulmonary embolism: an analysis of the national inpatient sample 2016–2018 Dae Yong ParkSeokyung AnShweta Gupta OriginalPaper 25 July 2022 Pages: 630 - 638
A survey of internists’ recommendations for aspirin in older adults and barriers to evidence-based use Jordan K. SchaeferGeoffrey D. BarnesJacob E. Kurlander OriginalPaper 14 June 2022 Pages: 639 - 646
Biomarkers associated with coronary high-risk plaques Akihiro NakajimaPeter LibbyIk-Kyung Jang OriginalPaper 07 October 2022 Pages: 647 - 659
Activated clotting time in inpatient diagnostic and interventional settings Heidi DaltonMichael MartinNichole Korpi-Steiner OriginalPaper Open access 22 June 2022 Pages: 660 - 668
Increased risk of venous thromboembolism among patients with familial Mediterranean fever Omer GendelmanAriel J FeifelHoward Amital OriginalPaper 14 October 2022 Pages: 669 - 674
Utilization trends and outcomes of catheter-directed thrombolysis for pulmonary embolism in the US by race/ethnicity Titilope OlanipekunTemidayo AbeDevang Sanghavi OriginalPaper 11 October 2022 Pages: 675 - 685
Thromboembolic complications of recreational nitrous oxide (ab)use: a systematic review Sanad OulkadiBenjamin PetersAnne-Sophie Vliegen ReviewPaper 27 June 2022 Pages: 686 - 695
Correction: Thrombotic and bleeding events, mortality, and anticoagulant use among 546,656 hospitalized patients with COVID‑19 in the United States: a retrospective cohort study Steve DeitelzweigXuemei LuoGregory Piazza Correction Open access 19 September 2022 Pages: 696 - 696